Endpoints and New Options for Treatment of Chronic Hepatitis D.
Journal Information
Full Title: Hepatology
Abbreviation: Hepatology
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Potential conflict of interest: Dr. Lok advises for and received grants from TARGET. She advises for Ambys, Bristol‐Myers Squibb, CLEAR‐B, GNI, and Eli Lilly. She received grants from Gilead. Dr. Negro consults for, advises for, and received grants from Gilead. He advises for AbbVie and Merck. Dr. Asselah consults for, advises for, is on the speakers’ bureau for, and received grants from Eiger, Gilead, and Myr. Dr. Rizzetto advises for Gilead."
"P.F. is supported by the Intramural Programs of the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Open Access Funding provided by Universita degli Studi di Torino within the CRUI‐CARE Agreement. [Correction added on 10 May, after first online publication: Open Access Funding provided by Universita degli Studi di Torino within the CRUI‐CARE Agreement funding statement has been added.] Potential conflict of interest: Dr. Lok advises for and received grants from TARGET. She advises for Ambys, Bristol‐Myers Squibb, CLEAR‐B, GNI, and Eli Lilly. She received grants from Gilead. Dr. Negro consults for, advises for, and received grants from Gilead. He advises for AbbVie and Merck. Dr. Asselah consults for, advises for, is on the speakers’ bureau for, and received grants from Eiger, Gilead, and Myr. Dr. Rizzetto advises for Gilead."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025